– Reuters
Miromatrix Medical Q1 EPS $(0.35) Misses $(0.29) Estimate
Miromatrix Medical (NASDAQ:MIRO) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.29) by 20.69 percent.
Related Posts
Morgan Stanley Maintains Equal-Weight on Equity Residential, Raises Price Target to $68
Morgan Stanley analyst Adam Kramer maintains Equity Residential (NYSE:EQR) with a Equal-Weight and raises the price target from $67 to $68.
Organicell Regenerative Medicine Announces Expansion Into Health And Beauty Market Through Partnership With BeautyHealth’s Hydrafacial
MIAMI, FL / ACCESSWIRE / September 16, 2022 / Organicell Regenerative Medicine, Inc.
Planet Fitness Pops After Q3 Earnings Beat
Planet Fitness Inc (NYSE:PLNT) reported third-quarter FY22 sales growth of 58.4% year-on-year to $244.39 million, beating the consensus of $234.99 million.…